FGF10 and chronic obstructive pulmonary disease: Pretreatment with AZD4547, a high-affinity FGFR inhibitor, markedly impaired the protective effect of FGF10 on 2% CSE stimulation for hPMVECs, suggesting that FGF10 may attenuate CSE-induced COPD through FGFR signaling.